| BE0320-50MG
| InVivoMAb anti-mouse Ly6G/Ly6C
| 50 mg
| BioXCell
| in vivo neutrophil depletion, Immunohistochemistry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0355-1MG
| InVivoMAb anti-human CA19-9
| 1 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0342-100MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 100 mg
| BioXCell
|
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0321-50MG
| InVivoMAb anti-mouse NKG2A/C/E
| 50 mg
| BioXCell
| in vivo NKG2A blockade (see description), in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0374-1MG
| InVivoMAb anti-mouse FAP
| 1 mg
| BioXCell
| Chimeric antigen receptor construction, Flow cytom
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0325-100MG
| InVivoMAb anti-West Nile/dengue virus E protein
| 100 mg
| BioXCell
| Neutralization of WNV, Neutralization of DENV1,2,3
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0319-5MG
| InVivoMAb anti-mouse FasL (CD178)
| 5 mg
| BioXCell
| in vivo FasL blockade, In vitro FasL blockade, Fun
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0328-1MG
| InVivoMAb anti-mouse CD28
| 1 mg
| BioXCell
| in vivo T cell stimulation/activation, in vitro T
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0370-5MG
| InVivoMAb anti-human CD71 (TfR1)
| 5 mg
| BioXCell
| Flow cytometry, Immunoprecipitation
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0304-25MG
| InVivoMAb anti-mouse BTLA (CD272)
| 25 mg
| BioXCell
| in vivo BTLA+ B cell and CD4 T cell depletion*, Fl
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0308-5MG
| InVivoMAb anti-rat CD4
| 5 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0332-100MG
| InVivoMAb anti-mouse FGL-1
| 100 mg
| BioXCell
| in vivo FGL-1 blockade, in vitro FGL-1 blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0324-1MG
| InVivoMAb anti-human/mouse denatured collagen type-I (RGD motif)
| 1 mg
| BioXCell
| Western blot, Immunofluorescence, in vivo administ
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0306-25MG
| InVivoMAb anti-human/monkey MHC class II (HLA-DR)
| 25 mg
| BioXCell
| in vitro blocking of MHC class II HLA-DR, HLA clas
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0337-50MG
| InVivoMAb anti-mouse CD96
| 50 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0337-1MG
| InVivoMAb anti-mouse CD96
| 1 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0324-25MG
| InVivoMAb anti-human/mouse denatured collagen type-I (RGD motif)
| 25 mg
| BioXCell
| Western blot, Immunofluorescence, in vivo administ
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0343-25MG
| InVivoMAb anti-human CD71 (TfR)
| 25 mg
| BioXCell
| Western blot, Immunoprecipitation, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0309-5MG
| InVivoMAb anti-mouse CXCL9 (MIG)
| 5 mg
| BioXCell
| in vivo CXCL9 neutralization, Immunofluorescence
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0323-50MG
| InVivoMAb anti-mouse TL1A (TNFSF15)
| 50 mg
| BioXCell
| in vivo TL1A neutralization, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0336-1MG
| InVivoMAb anti-human MUC1 (CD227)
| 1 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0300-5MG
| InVivoMAb anti-mouse CD45.2
| 5 mg
| BioXCell
| Flow cytometry, in vivo CD45.2 blockade, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0351-50MG
| InVivoMAb anti-human NKG2D (CD314)
| 50 mg
| BioXCell
| in vitro NKG2D blocking, Immunoprecipitation, Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0366-100MG
| InVivoMAb mouse IgG2c isotype control, anti-dengue virus
| 100 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0371-1MG
| InVivoMAb anti-mouse IL-12 p35
| 1 mg
| BioXCell
| in vivo IL-12 p35 neutralization, in vitro IL-12 p
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0377-1MG
| InVivoMAb anti-mouse CD31 (PECAM-1)
| 1 mg
| BioXCell
| in vivo CD31 blocking, Intravital imaging, Immunof
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0339-1MG
| InVivoMAb anti-mouse NKG2AB6
| 1 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0351-100MG
| InVivoMAb anti-human NKG2D (CD314)
| 100 mg
| BioXCell
| in vitro NKG2D blocking, Immunoprecipitation, Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0356-25MG
| InVivoMAb anti-mouse CD20
| 25 mg
| BioXCell
| in vivo B cell depletion, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|